Table 3.

Medications for Opioid Use Disorder After Non-Fatal Overdose by Medication Type

Medication type	After overdose, n (%)	Unadjusted odds ratio	p value	Adjusted odds ratio	p value
Any MOUD (n = 526, 3.2%)
White	379 (2.9)	Reference		Reference
Black	107 (4.6)	1.64 (1.31, 2.04)	< 0.001	1.55 (1.22, 1.96)	< 0.001
Hispanic	40 (5.5)	1.97 (1.41, 2.75)	< 0.001	1.76 (1.21, 2.56)	0.003
Buprenorphine (n = 212, 1.3%)
White	168 (1.3)	Reference		Reference
Black	25 (1.1)	0.85 (0.55, 1.29)	0.44	0.97 (0.62, 1.51)	0.90
Hispanic	19 (2.6)	2.08 (1.29, 3.37)	0.003	1.96 (1.16, 3.32)	0.01
Methadone (n = 307, 1.9%)
White	202 (1.5)	Reference		Reference
Black	84 (3.6)	2.42 (1.87, 3.13)	< 0.001	1.91 (1.44, 2.53)	< 0.001
Hispanic	21 (2.9)	1.92 (1.21, 3.02)	0.005	1.59 (0.96, 2.63)	0.07
Naltrexone (n = 61, 0.4%)
White	49 (0.4)	Reference		Reference
Black	5 (0.2)	0.58 (0.23, 1.46)	0.25	0.61 (0.24, 1.57)	0.30
Hispanic	7 (1.0)	2.61 (1.18, 5.78)	0.02	2.22 (0.93, 5.30)	0.07

Adjusted models control for categorical age, sex, Gagne Index, prescription insurance status, driving distance to the nearest VA primary clinic, region, rurality, and VA priority status